Literature DB >> 22463131

Blood biomarkers in stroke: research and clinical practice.

William Whiteley1, Yingfang Tian, Glen C Jickling.   

Abstract

Blood biomarkers may have applications in stroke diagnosis, outcome prediction, or treatment. In this article, we provide a focused review on some of the methodological challenges and potential developments of biomarkers in stroke. We review the approaches to the development of a diagnostic blood marker: a candidate marker approach, marker panels, and -omics. Then we examined the role of blood markers to predict recurrent stroke and treatment response in stroke.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22463131     DOI： 10.1111/j.1747-4949.2012.00784.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN： 1747-4930            Impact factor:   5.266


  17 in total

1.  Metabolomics predicts stroke recurrence after transient ischemic attack.

Authors:  Mariona Jové; Gerard Mauri-Capdevila; Idalmis Suárez; Serafi Cambray; Jordi Sanahuja; Alejandro Quílez; Joan Farré; Ikram Benabdelhak; Reinald Pamplona; Manuel Portero-Otín; Francisco Purroy
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

2.  Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?

Authors:  Heidi Ormstad; Robert Verkerk; Leiv Sandvik
Journal:  J Mol Neurosci       Date:  2015-09-30       Impact factor: 3.444

Review 3.  [Glial fibrillary acidic protein in patients with symptoms of acute stroke: diagnostic marker of cerebral hemorrhage].

Authors:  C Foerch; W Pfeilschifter; P Zeiner; R Brunkhorst
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 4.  Blood Biomarkers for Stroke Diagnosis and Management.

Authors:  Joseph Kamtchum-Tatuene; Glen C Jickling
Journal:  Neuromolecular Med       Date:  2019-03-04       Impact factor: 3.843

5.  Remote ischemic preconditioning in the prevention of ischemic brain damage during intracranial aneurysm treatment (RIPAT): study protocol for a randomized controlled trial.

Authors:  Selma Tülü; Miriam Mulino; Daniel Pinggera; Markus Luger; Philipp Würtinger; Astrid Grams; Thomas Bodner; Ronny Beer; Raimund Helbok; Raffaella Matteucci-Gothe; Claudia Unterhofer; Elke Gizewski; Erich Schmutzhard; Claudius Thomé; Martin Ortler
Journal:  Trials       Date:  2015-12-29       Impact factor: 2.279

6.  Biomarkers and perfusion--training-induced changes after stroke (BAPTISe): protocol of an observational study accompanying a randomized controlled trial.

Authors:  Alexander H Nave; Jan M Kröber; Peter Brunecker; Jochen B Fiebach; Jonathan List; Ulrike Grittner; Matthias Endres; Andreas Meisel; Agnes Flöel; Martin Ebinger
Journal:  BMC Neurol       Date:  2013-12-11       Impact factor: 2.474

7.  Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke.

Authors:  Svetlana A Dambinova; Kerstin Bettermann; Theodore Glynn; Matthew Tews; David Olson; Joseph D Weissman; Richard L Sowell
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans.

Authors:  Guangwen Long; Feng Wang; Huaping Li; Zhongwei Yin; Chaugai Sandip; Yan Lou; Yan Wang; Chen Chen; Dao Wen Wang
Journal:  BMC Neurol       Date:  2013-11-16       Impact factor: 2.474

Review 9.  Finding an optimal rehabilitation paradigm after stroke: enhancing fiber growth and training of the brain at the right moment.

Authors:  Anna-Sophia Wahl; Martin E Schwab
Journal:  Front Hum Neurosci       Date:  2014-06-27       Impact factor: 3.169

10.  Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke.

Authors:  R Zangari; E R Zanier; G Torgano; A Bersano; S Beretta; E Beghi; B Casolla; N Checcarelli; S Lanfranconi; A Maino; C Mandelli; G Micieli; F Orzi; E Picetti; M Silvestrini; N Stocchetti; B Zecca; P Garred; M G De Simoni
Journal:  J Neuroinflammation       Date:  2016-01-20       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.